Amifostine Patent Expiration

Amifostine is Used for administering the drug product. It was first introduced by Cosette Pharmaceuticals Inc in its drug Ethyol on Dec 8, 1995. 3 different companies have introduced drugs containing Amifostine.


Amifostine Patents

Given below is the list of patents protecting Amifostine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ethyol US5994409 Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds Dec 08, 2017

(Expired)

Cosette
Ethyol US5424471 Crystalline amifostine compositions and methods of the preparation and use of same Jul 31, 2012

(Expired)

Cosette
Ethyol US5591731 Crystalline amifostine compositions Jul 31, 2012

(Expired)

Cosette



Amifostine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amifostine Generic API Manufacturers

Several generic applications have been filed for Amifostine. The first generic version for Amifostine was by Sun Pharmaceutical Industries Ltd and was approved on Mar 14, 2008. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Jul 17, 2017.

Given below is the list of companies who have filed for Amifostine generic, along with the locations of their manufacturing plants worldwide.